1. Effects of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, on lipid profiling in patients with type 2 diabetes. (25th November 2020) Authors: Ruotolo, G; Roth, K.D; Milligan, P.L; Lin, Y; Wilson, J.M; Pirro, V; Duffin, K.L; Haupt, A Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗